The Cosmetic Physicians College of Australasia (CPCA) has today released a statement regarding cosmetic restrictions amid the current COVID-19 climate.
According to the leading representative body, anti-wrinkle injections (Botox, Dysport and Xeomin as Botulinum Toxin A) and dermal fillers, when performed for cosmetic purposes, should cease from midnight on March 31.
“While these procedures are categorised as being only to be performed by authorised health practitioners, patient safety is the College’s primary consideration in an effort to reduce the spread of this disease,” the statement reads.
The statement also added that therapeutic uses of these prescription-only products should be carefully considered by medical practitioners, saying, “Therapeutic uses of scheduled, prescription only medications should only be performed following the instructions by the Chief Medical Officer and Prime Minister’s announcements.”
Although this ban exempts “health services provided by health practitioners registered under the Health Practitioner Regulation National Law,” the statement made clear that medical procedures, involving the administration of prescription-only, scheduled medications within premises that are not classified as medical facilities, such as hairdressers, medi-spas and beauticians, or where there is no medical practitioner on-site, must immediately cease.
“The CPCA has consistently shown grave concern preceding this pandemic over the administration of medical substances on these types of non-medical premises. This is now particularly accentuated during the course of this highly contagious pandemic.”
